Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

685 public trials 115 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer

NCT00051051

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Pfizer Investigational Site Montgomery, Alabama, United States
  • Pfizer Investigational Site Arroyo Grande, California, United States
  • Pfizer Investigational Site Montebello, California, United States
  • Pfizer Investigational Site San Francisco, California, United States
View all 66 locations
View Trial Details
Completed

A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer

NCT00034827

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +24 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Blendora, California, United States
  • Pfizer Investigational Site Glendale, California, United States
View all 30 locations
View Trial Details
Completed

A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer

NCT00191672

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CT-LILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nashville, Tennessee, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM - 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Katy, Texas, United States
View Trial Details
Completed

Raloxifene Use for The Heart

NCT00190593

Conditions
Breast Diseases, Breast Neoplasms, Cardiovascular Diseases, +4 more
Locations
  • For additonal information regarding investigative sites for this trial, please call 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Monday-Friday, 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician Minneapolis, Minnesota, United States
View Trial Details

Related conditions